276 related articles for article (PubMed ID: 24861491)
1. Pathogenetic mechanisms of focal cortical dysplasia.
Marin-Valencia I; Guerrini R; Gleeson JG
Epilepsia; 2014 Jul; 55(7):970-8. PubMed ID: 24861491
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
Jeong A; Wong M
J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
[TBL] [Abstract][Full Text] [Related]
3. Precision Therapy for Epilepsy Related to Brain Malformations.
D'Gama AM; Poduri A
Neurotherapeutics; 2021 Jul; 18(3):1548-1563. PubMed ID: 34608615
[TBL] [Abstract][Full Text] [Related]
4. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
[TBL] [Abstract][Full Text] [Related]
5. Focal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications.
Iffland PH; Crino PB
Annu Rev Pathol; 2017 Jan; 12():547-571. PubMed ID: 28135561
[TBL] [Abstract][Full Text] [Related]
6. Focal malformations of cortical development: new vistas for molecular pathogenesis.
Lim KC; Crino PB
Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
[TBL] [Abstract][Full Text] [Related]
7. New developments in understanding focal cortical malformations.
Becker AJ; Beck H
Curr Opin Neurol; 2018 Apr; 31(2):151-155. PubMed ID: 29278549
[TBL] [Abstract][Full Text] [Related]
8. Focal cortical dysplasia: Updates.
Pinheiro J; Honavar M
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S189-S197. PubMed ID: 35562149
[TBL] [Abstract][Full Text] [Related]
9. mTOR signaling in epilepsy: insights from malformations of cortical development.
Crino PB
Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
Wong M
Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
[TBL] [Abstract][Full Text] [Related]
11. Hyperactive mTOR signals in the proopiomelanocortin-expressing hippocampal neurons cause age-dependent epilepsy and premature death in mice.
Matsushita Y; Sakai Y; Shimmura M; Shigeto H; Nishio M; Akamine S; Sanefuji M; Ishizaki Y; Torisu H; Nakabeppu Y; Suzuki A; Takada H; Hara T
Sci Rep; 2016 Mar; 6():22991. PubMed ID: 26961412
[TBL] [Abstract][Full Text] [Related]
12. Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement.
Hsieh LS; Wen JH; Claycomb K; Huang Y; Harrsch FA; Naegele JR; Hyder F; Buchanan GF; Bordey A
Nat Commun; 2016 Jun; 7():11753. PubMed ID: 27249187
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
[TBL] [Abstract][Full Text] [Related]
14. GATORopathies: The role of amino acid regulatory gene mutations in epilepsy and cortical malformations.
Iffland PH; Carson V; Bordey A; Crino PB
Epilepsia; 2019 Nov; 60(11):2163-2173. PubMed ID: 31625153
[TBL] [Abstract][Full Text] [Related]
15. Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.
Wong M
Epilepsia; 2009 Oct; 50 Suppl 9(0 9):34-44. PubMed ID: 19761452
[TBL] [Abstract][Full Text] [Related]
16. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
Nguyen LH; Mahadeo T; Bordey A
J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
[TBL] [Abstract][Full Text] [Related]
17. mTOR-dependent alterations of Kv1.1 subunit expression in the neuronal subset-specific Pten knockout mouse model of cortical dysplasia with epilepsy.
Nguyen LH; Anderson AE
Sci Rep; 2018 Feb; 8(1):3568. PubMed ID: 29476105
[TBL] [Abstract][Full Text] [Related]
18. Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias.
Orlova KA; Tsai V; Baybis M; Heuer GG; Sisodiya S; Thom M; Strauss K; Aronica E; Storm PB; Crino PB
J Neuropathol Exp Neurol; 2010 Aug; 69(8):850-63. PubMed ID: 20613634
[TBL] [Abstract][Full Text] [Related]
19. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
[TBL] [Abstract][Full Text] [Related]
20. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
